VPRIV Powder for Solution for Infusion
Velaglucerase alfa
400 U
Cangene BioPharma Inc. (CBI)
| Pack size | 1 Vial |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 6118.55 AED |
Indications
VPRIV Powder for Solution for Infusion is used for:
Velaglucerase alfa is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for pediatric and adult patients with type 1 Gaucher disease.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Velaglucerase alfa :
Mechanism of Action
Velaglucerase alfa catalyzes the hydrolysis of glucocerebroside, reducing the amount of accumulated glucocerebroside.
Note
VPRIV 400 U Powder for Solution for Infusion manufactured by Cangene BioPharma Inc. (CBI). Its generic name is Velaglucerase alfa. VPRIV is availble in Saudi Arabia.
Farmaco SA drug index information on VPRIV Powder for Solution for Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.